Peter P Sordillo
Overview
Explore the profile of Peter P Sordillo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
309
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sordillo L, Sordillo P
Anticancer Res
. 2023 Nov;
43(12):5275-5282.
PMID: 38030171
Kynurenine 3-monooxygenase (KMO), a key enzyme within the kynurenine (KYN) pathway of tryptophan (TRY) metabolism, enables the excess production of toxic metabolites (such as 3-hydroxykynurenine, xanthurenic acid, 3-hydroxyanthranilic acid and...
2.
Sordillo P, Allaire A, Bouchard A, Salvail D, Labbe S
Pharm Biol
. 2022 Jul;
60(1):1255-1263.
PMID: 35786152
Context: Acute respiratory distress syndrome (ARDS) is a highly fatal, inflammatory condition of lungs with multiple causes. There is no adequate treatment. Objective: Using the murine LPS-induced ARDS model, we...
3.
Sordillo P, Sordillo L
Anticancer Res
. 2020 Mar;
40(3):1189-1200.
PMID: 32132016
The majority of patients receiving chemotherapy experience post-chemotherapy cognitive impairment, sometimes referred to as "chemo brain" or "chemo fog." The cognitive impairment associated with this syndrome can be severe, and...
4.
Bolger G, Licollari A, Tan A, Greil R, Vcelar B, Greil-Ressler S, et al.
Cancer Chemother Pharmacol
. 2018 Nov;
83(2):265-275.
PMID: 30430227
Purpose: Investigation of the impact of co-medication on the plasma levels of curcumin and tetrahydrocurcumin (THC) in cancer patients and a comparison of the pharmacokinetics of curcumin and plasma levels...
5.
Greil R, Greil-Ressler S, Weiss L, Schonlieb C, Magnes T, Radl B, et al.
Cancer Chemother Pharmacol
. 2018 Aug;
82(4):695-706.
PMID: 30074076
Purpose: This study was conducted to investigate the safety and tolerability of increasing doses of liposomal curcumin in patients with metastatic cancer. Investigations of anti-tumor activity and of the pharmacokinetics...
6.
Sordillo P, Sordillo L, Helson L
Anticancer Res
. 2017 May;
37(5):2159-2171.
PMID: 28476779
The failure of chemotherapy and radiation therapy to achieve long-term remission or cure in patients with glioblastoma (GBM) is, in a large part, due to the suppression of the immune...
7.
Sordillo D, Sordillo L, Sordillo P, Shi L, Alfano R
J Biomed Opt
. 2017 Apr;
22(4):45002.
PMID: 28384701
There are three short wavelength infrared (SWIR) optical windows outside the conventionally used first near-infrared (NIR) window (650 to 950 nm). They occur in the 1000- to 2500-nm range and...
8.
Liu C, Boydston-White S, Weisberg A, Wang W, Sordillo L, Perotte A, et al.
J Biomed Opt
. 2016 Dec;
21(12):127006.
PMID: 27999865
A clear correlation has been observed between the resonance Raman (RR) spectra of plaques in the aortic tunica intimal wall of a human corpse and three states of plaque evolution:...
9.
Sordillo P, Sordillo L, Helson L
Brain Inj
. 2016 Jun;
30(9):1043-53.
PMID: 27261102
Background: Pro-inflammatory cytokines play an essential role in maintenance of normal brain function as well as in repair after traumatic brain injuries (TBI). However, massive and uncontrolled release of these...
10.
Sphingosine Kinase Inhibitors as Maintenance Therapy of Glioblastoma After Ceramide-Induced Response
Sordillo L, Sordillo P, Helson L
Anticancer Res
. 2016 Apr;
36(5):2085-95.
PMID: 27127108
Ceramide and sphingosine 1-phosphate (S1P) are sphingolipid metabolites with important signaling functions. Ceramides promote apoptosis, whereas S1P favors proliferation, angiogenesis and cell survival. The balance between these opposing signaling functions...